The China endoscopy devices market size was estimated at USD 4.3 billion in 2023 and is projected to reach USD 9.04 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.98% from 2024 to 2030. The market growth is primarily driven by the rising adoption of endoscopy devices, particularly endoscopes and visualization systems, across a wide range of healthcare settings. The increasing preference for endoscopic procedures among healthcare professionals stems from their ability to provide accurate diagnostics and minimally invasive surgical interventions, which result in better patient outcomes and lower recovery times. Moreover, China’s rapidly aging population, which is more prone to developing conditions requiring endoscopic intervention such as intestinal perforation, gallstones, pelvic abscesses, endometriosis, and liver abscesses is further fueling market demand. According to a World Health Organization (WHO) report published in 2021, approximately 28.0% of China’s population will be aged 60 years and above by 2040, representing a significant demographic shift that will contribute to the growing need for endoscopy-based medical procedures.

Technological advancements in minimally invasive surgery (MIS) have proven highly beneficial, particularly in the management of morbid obesity and related metabolic disorders, as well as various gastrointestinal and urological conditions. The use of endoscopic devices in both clinical diagnosis and therapeutic procedures has become increasingly widespread due to their ability to facilitate precise, minimally invasive interventions. These procedures allow for smaller incisions, less muscle disruption, and greater preservation of healthy tissue, which collectively reduce surgical complications and accelerate patient recovery. Compared with traditional open surgeries, endoscopic procedures also offer economic advantages, including lower healthcare costs, reduced post-operative complications, shorter hospital stays, faster rehabilitation, and minimal intraoperative blood loss. As a result, both patients and healthcare providers are increasingly recognizing endoscopy as a safer and more cost-effective alternative, which continues to propel the market forward.

Overall, the market growth remains moderate but accelerating, supported by the ongoing shift toward minimally invasive medical practices and the rising burden of chronic diseases. The competitive landscape is moderately fragmented, with several key players actively contributing to innovation through strategic initiatives, product launches, research and development activities, and geographic expansion. Continuous investments in advanced imaging technologies, robotics, and flexible endoscopes are also enhancing diagnostic precision and expanding the range of procedures that can be performed endoscopically, thereby strengthening market potential in China.

Key Market Trends & Insights:

• Based on End-use: The hospital segment led the market with a share of 46.73% in 2023, primarily due to the growing number of surgical procedures performed in hospital settings and the extensive presence of hospitals and primary care centers across China. Meanwhile, the Ambulatory Surgery Centers (ASCs)/clinics segment is projected to grow at the fastest rate from 2024 to 2030, driven by the rising popularity of day-care surgeries, shorter recovery periods, and the cost-effectiveness of outpatient procedures.
• Based on Product: The endoscopy visualization components segment dominated the market in 2023 with a revenue share of 34.3%, owing to the increasing adoption of high-definition imaging systems, 3D visualization, and advanced camera technologies that enhance surgical precision. These visualization systems are critical in improving diagnostic accuracy and procedural safety. The endoscopes segment, on the other hand, is anticipated to grow at a lucrative CAGR during the forecast period, supported by continuous innovations such as disposable and flexible endoscopes, which help reduce the risk of cross-contamination and improve procedural efficiency.
• Based on Application: The gastrointestinal (GI) endoscopy segment dominated the market, holding a major share of 55.52%, owing to the high prevalence of gastrointestinal disorders and the increasing use of endoscopy for diagnosing and treating diseases such as ulcers, colon polyps, and colorectal cancer. The urology endoscopy (cystoscopy) segment is expected to grow at the fastest rate over the forecast period, driven by the rising incidence of urinary tract disorders, kidney stones, and prostate-related conditions. Increasing awareness of early diagnosis and improvements in urology device technology are further accelerating growth in this segment.

Order a free sample PDF of the China Endoscopy Devices Market Intelligence Study, published by Grand View Research.

Key Companies & Market Share Insights:

The China endoscopy devices market is highly fragmented, with a mix of international and domestic manufacturers competing for market share. Prominent players include Boston Scientific Corporation, Olympus Corporation, Stryker Corporation, Zhejiang Tiansong Medical Instrument Co., Ltd., and PENTAX Medical. These companies account for a substantial share of the market owing to their broad product portfolios, strong distribution networks, and commitment to continuous innovation. The overall market growth is being reinforced by several key factors, including the rising demand for minimally invasive surgeries, the increasing number of trained endoscopists, and the development of new and improved surgical instruments that expand the indications for endoscopic procedures.

Furthermore, mergers and acquisitions (M&A), large-scale investments in research and development (R&D), and the introduction of technologically advanced products remain central to the strategic growth initiatives adopted by market participants. Companies are focusing on product modifications, strategic collaborations, and joint ventures to strengthen their presence in both domestic and regional markets. Strategic alliances between manufacturers and healthcare providers are also playing a critical role in enhancing procedural accessibility, promoting clinical training programs, and boosting the overall adoption of endoscopic technologies across China.

Explore our latest blogs: Global Industry Herald

Conclusion:

In conclusion, the China endoscopy devices market is expected to witness strong and sustained growth over the coming years, driven by technological advancements, increasing adoption of minimally invasive procedures, and the growing prevalence of age-related diseases. The expanding elderly population and rising healthcare investments are creating favorable conditions for the broader use of endoscopic technologies across hospitals and outpatient centers. Continuous product innovation, particularly in visualization systems and flexible endoscopes, is enhancing diagnostic precision and procedural safety, further boosting market demand. Although the market remains moderately competitive, strategic collaborations, mergers, and research initiatives are likely to strengthen the positions of leading players. Overall, the market outlook remains highly positive, supported by government healthcare initiatives and the rising demand for efficient, patient-friendly surgical solutions.